COMMUNIQUÉS West-GlobeNewswire

AIT Therapeutics to Present at Two Investor Conferences
07/03/2018
REHOVOT, Israel and NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients [...]
HTG Molecular Diagnostics to Announce Fourth Quarter and Year-End Financial Results and Host Conference Call on Thursday, March 22
07/03/2018
TUCSON, Ariz., March 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will [...]
Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in March
07/03/2018
BOSTON, March 07, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM ), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of [...]
Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update
07/03/2018
Xtampza ER prescriptions grew by 37% in the fourth quarter FDA Approval of sNDA, including Comparative OxyContin Data in label Expanded product portfolio by licensing rights to commercialize Nucynta franchise Revenue [...]
Trevena to Present at the Cowen and Company 38th Annual Healthcare Conference
07/03/2018
CHESTERBROOK, Pa., March 07, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Cowen and Company 38th Annual Healthcare Conference on Wednesday, March 14, 2018, at [...]
Acer Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
07/03/2018
NEWTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]
Celldex Provides Corporate Update and Reports Full Year 2017 Results
07/03/2018
HAMPTON, N.J., March 07, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX ) today reported business and financial highlights for the fourth quarter and year ended December 31, 2017. The Company will [...]
Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update
07/03/2018
Two novel anti-epileptic drugs advancing in clinical development; Interim XEN1101 Phase 1 data expected to be released in May 2018 at scientific symposium; Xenon announces new clinical stage ion channel product to [...]
Aduro Biotech to Present at the 38th Annual Cowen Healthcare Conference
07/03/2018
BERKELEY, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Andrea van Elsas, chief scientific officer of Aduro, will present at the 38th Annual Cowen Healthcare [...]
REVA Medical Reports Fourth Quarter and Full Year 2017 Financial Results
07/03/2018
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular medical applications, today reported financial results [...]
Veloxis Files with FDA for the De Novo Indication for ENVARSUS XR
07/03/2018
Company Release no. 03/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 07 March 2018 Veloxis Files with FDA for the De Novo Indication for ENVARSUS XR® Veloxis Pharmaceuticals A/S announced today that it has [...]
Vitrea® Intelligence Enables Imaging Queensland to Optimize Operations Across its Enterprise
07/03/2018
MINNETONKA, Minn., March 07, 2018 (GLOBE NEWSWIRE) -- Vital Images announced today that its enterprise analytics solution, Vitrea Intelligence, will be deployed at Imaging Queensland, a premier imaging network in [...]
Sanofi: Filing of the 2017 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report
07/03/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Filing of the 2017 U.S. Form 20-F and French « Document de Référence » containing the Annual Financial Report PARIS, France - March 7, 2018 - Sanofi announces [...]
Sanofi : Dépôt du Document de Référence 2017, contenant le Rapport Financier Annuel, et du « Form 20-F » américain
07/03/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Dépôt du Document de Référence 2017, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Paris (France) - Le 7 mars 2018 - Sanofi [...]
Matrix Medical Network puts a 40-foot Mobile Clinic into a 20-foot Exhibit Booth
07/03/2018
SCOTTSDALE, Ariz., March 07, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix) has harnessed the power of new 3D 360-degree virtual reality technology to transport RISE Nashville Summit attendees into one of its [...]
Diaxonhit se positionne sur le marché de la médecine personnalisée en oncologie
07/03/2018
Diaxonhit se positionne sur le marché de la médecine personnalisée en oncologie Diaxonhit devient le distributeur exclusif en France de la gamme MyCare de Saladax Biomedical Une gamme de tests sanguins pouvant être [...]
Bavarian Nordic to Host Full Year 2017 Results Conference Call
07/03/2018
COPENHAGEN, Denmark - March 7, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2017 annual report on Monday, March 12, 2018. The management of Bavarian Nordic will host a conference call at 2:00 pm [...]
Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement
07/03/2018
Regulated Information - Inside Information - 7 March 2018 - 4 pm CET NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, [...]
Bone Therapeutics collecte 19,45 M€ d'engagements dans le cadre d'un placement d'obligations convertibles
07/03/2018
Information réglementée - Information confidentielle - 7 mars 2018 - 16h00 CET LE PRÉSENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, TOTALEMENT OU PARTIELLEMENT, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS- [...]

Pages